Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients With Established COVID-19
Sponsor: Rabin Medical Center
Terminated
End of COVID-19 outbreak in Israel
Other terminated trials from Rabin Medical Center
Other COVID 19 trials with similar outcome
This PHASE3 trial investigates COVID 19 and Coronavirus and is currently terminated or withdrawn. Rabin Medical Center leads this study, which shows 8 recorded versions since 2020 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
8 versions recorded-
Sep 2025 — Present [monthly]
Terminated PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Terminated PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE3
-
Sep 2021 — Jul 2024 [monthly]
Terminated PHASE3
Status: Recruiting → Terminated
-
Apr 2021 — Sep 2021 [monthly]
Recruiting PHASE3
▶ Show 3 earlier versions
-
Jan 2021 — Apr 2021 [monthly]
Recruiting PHASE3
-
Oct 2020 — Jan 2021 [monthly]
Recruiting PHASE3
Status: Not Yet Recruiting → Recruiting
-
Jun 2020 — Oct 2020 [monthly]
Not Yet Recruiting PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Rabin Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .